Clinical Trial Update: A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and effectiveness of apixaban to prevent blood clots in children with leukemia and a central venous catheter treated with aspara…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Lymphoma

Drugs mentioned

• Apixaban (apixaban)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Lymphoma, Acute Lymphoblastic Leukemia | Phase 3 | Status: COMPLETED | Results posted: 2022-03-08